Alyeska Investment Group’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-70,000
Closed -$1.86M 506
2018
Q2
$1.86M Buy
+70,000
New +$1.9M 0.02% 358

Other funds holding STIM

Alyeska Investment Group's STIM Position: Q3 2018 in Review

Alyeska Investment Group sold out of Neuronetics (STIM) in Q3 2018, closing a stake of 70,000 shares — an estimated $1.86M sold.

Alyeska Investment Group first reported a position in STIM in Q2 2018 and held it in 1 quarter. The position peaked at $1.86M in Q2 2018. 74 funds tracked by Wall St. Rank hold STIM as of Q3 2018.

  • Alyeska Investment Group reported no remaining Neuronetics position as of Q3 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 70,000 Neuronetics shares in Q3 2018, an estimated $1.86M.
  • Alyeska Investment Group first reported a position in Neuronetics in Q2 2018 and held it in 1 quarter.
  • Alyeska Investment Group's Neuronetics position peaked at $1.86M in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Neuronetics as of Q3 2018.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.